Women's Heart Advisor October 2009 Issue

The Pill Box: Bisphosphonates

Good for the bones…and maybe safe for the heart after all.

Bisphosphonates are widely prescribed to build bone mass and decrease the risk of fracture in women with osteoporosis. So in 2007 when the New England Journal of Medicine published a meta-analysis of randomized, controlled trials connecting bisphosphonate use with increased risk of atrial fibrillation (AF), women and their physicians sat up and took notice. So did the FDA, which immediately conducted a review of all clinical trial data that had led to this conclusion. One year later, the FDA published a statement saying no clear association between bisphosphonate use and AF, regardless of dosage or length of exposure, could be confirmed.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.